| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.96.3.769 |
| P698 | PubMed publication ID | 9264481 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hirudin | Q386715 |
| myocardial ischemia | Q6947906 | ||
| heparin | Q190016 | ||
| P304 | page(s) | 769-777 | |
| P577 | publication date | 1997-08-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Comparison of the effects of two doses of recombinant hirudin compared with heparin in patients with acute myocardial ischemia without ST elevation: a pilot study. Organization to Assess Strategies for Ischemic Syndromes (OASIS) Investigators | |
| P478 | volume | 96 |
| Q35159127 | A novel approach to thrombin inhibition |
| Q59356505 | ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the M |
| Q33655204 | Advances in the medical management of acute coronary syndromes |
| Q33671937 | Anticoagulant therapy in unstable angina. |
| Q47911391 | Antithrombin agents as anticoagulants and antithrombotics. Implications in drug development |
| Q43542510 | Antithrombotic effect of LB-30057 (CI-1028), a new synthetic thrombin inhibitor, in a rabbit model of thrombosis: comparison with inogatran |
| Q34336816 | Bivalirudin for percutaneous coronary intervention and in acute coronary syndromes |
| Q35566175 | Clinician update: direct thrombin inhibitors in acute coronary syndromes |
| Q24186056 | Comparison of central adjudication of outcomes and onsite outcome assessment on treatment effect estimates |
| Q33340032 | Concurrent use of reteplase and lepirudin in the treatment of acute anterior wall myocardial infarction |
| Q34995139 | Defining the scope of evidence-based practice for low-molecular-weight heparin therapy in high-risk patients with unstable angina and non-ST-elevation myocardial infarction. |
| Q73039467 | Design, baseline characteristics, and preliminary clinical results of the Organization to Assess Strategies for Ischemic Syndromes-2 (OASIS-2) trial |
| Q34059396 | Desirudin: a review of its use in the management of thrombotic disorders |
| Q33178870 | Development of the Na+/H+ exchange inhibitor cariporide as a cardioprotective drug: from the laboratory to the GUARDIAN trial |
| Q56003309 | Direct thrombin inhibitors |
| Q34027292 | Direct thrombin inhibitors as adjuncts to thrombolytic therapy |
| Q30671597 | Direct thrombin inhibitors in acute coronary syndromes: principal results of a meta-analysis based on individual patients' data |
| Q77309612 | Ecarin clotting time but not aPTT correlates with PEG-hirudin plasma activity |
| Q74012811 | Effects of various anticoagulant treatments on von Willebrand factor release in unstable angina |
| Q33735581 | Future directions in thrombolysis. |
| Q47281565 | Hirudin versus heparin and low-molecular-weight heparin: and the winner is... |
| Q33671970 | Management of high-risk subsets in unstable angina |
| Q34820259 | Management of patients with acute coronary syndromes: what is the clinical role of direct thrombin inhibitors? |
| Q58386649 | Marginal Analysis of Point Processes with Competing Risks |
| Q52541865 | Multiple mechanisms of thrombosis complicating atherosclerotic plaques. |
| Q77183613 | New anticoagulant drugs |
| Q28193946 | Pharmacological treatment of elderly patients with acute coronary syndromes without persistent ST segment elevation |
| Q35803300 | Recent advances in the management of unstable angina and non-Q-wave myocardial infarction |
| Q41744467 | Recent advances. Cardiology |
| Q73039466 | The Organization to Assess Strategies for Ischemic Syndromes (OASIS) Pilot Study: evaluation of acute and long-term therapies for patients with acute coronary syndromes without ST elevation |
| Q35088077 | The evolving role of direct thrombin inhibitors in acute coronary syndromes |
| Q33671919 | Thrombosis and coagulation abnormalities in the acute coronary syndromes |
| Q41667008 | Thrombosis, antithrombotic agents, and the antithrombotic approach in cardiac disease |
| Q72999601 | Treatment of unstable angina: role of antithrombotic therapy |
| Q33333960 | Use of direct thrombin inhibitors in acute coronary syndrome |
| Q73446080 | [Direct thrombin inhibitors: their role in the treatment of arterial and venous thrombosis] |
| Q73038813 | [Therapy of acute coronary syndrome. Aspirin, heparin, low-molecular-weight heparin, hirudin and GP-IIb/IIIa blockers] |
| Q26829973 | 2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Associat |
Search more.